Abiopharma

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

OTC Markets Group Welcomes Orvana Minerals Corp. to OTCQX

Green Stream Holdings, Inc. Announces New Leadership and Board Appointments and Strategic Direction Involving Law90 and Subsidiaries

Forgent Power Solutions Announces Pricing of Public Offering of Class A Common Stock

Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025

Legence Reports Fourth Quarter and Year End 2025 Financial Results